US2585815A
(en)
|
1947-01-16 |
1952-02-12 |
Mclintock Duncan Menzies |
Injection syringe
|
US2564977A
(en)
|
1949-01-19 |
1951-08-21 |
Hu Quang Hsi |
Medical injecting apparatus
|
US3232117A
(en)
|
1962-09-14 |
1966-02-01 |
Roger Gilmont Instr Inc |
Micrometer buret
|
US3416530A
(en)
|
1966-03-02 |
1968-12-17 |
Richard A. Ness |
Eyeball medication dispensing tablet
|
US3618604A
(en)
|
1969-06-09 |
1971-11-09 |
Alza Corp |
Ocular insert
|
US3641237A
(en)
|
1970-09-30 |
1972-02-08 |
Nat Patent Dev Corp |
Zero order release constant elution rate drug dosage
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US3831583A
(en)
|
1971-03-05 |
1974-08-27 |
Univ California |
Implantable bulb for inflation of surgical implements
|
US3995635A
(en)
|
1971-09-09 |
1976-12-07 |
Alza Corporation |
Ocular insert
|
US3828777A
(en)
|
1971-11-08 |
1974-08-13 |
Alza Corp |
Microporous ocular device
|
US3845201A
(en)
|
1972-04-24 |
1974-10-29 |
S Loucas |
Solid state ophthalmic medication delivery method
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3914402A
(en)
|
1973-06-14 |
1975-10-21 |
Alza Corp |
Ophthalmic dosage form, for releasing medication over time
|
US4179497A
(en)
|
1973-12-17 |
1979-12-18 |
Merck & Co., Inc. |
Solid state ophthalmic medication
|
US3902495A
(en)
|
1974-01-28 |
1975-09-02 |
Cavitron Corp |
Flow control system
|
US3961628A
(en)
|
1974-04-10 |
1976-06-08 |
Alza Corporation |
Ocular drug dispensing system
|
US3949748A
(en)
|
1974-09-26 |
1976-04-13 |
Oscar Malmin |
Injection syringe having aspirating and metering capabilities
|
US3949750A
(en)
|
1974-10-07 |
1976-04-13 |
Freeman Jerre M |
Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
|
US3926188A
(en)
|
1974-11-14 |
1975-12-16 |
Alza Corp |
Laminated drug dispenser
|
US4096238A
(en)
|
1974-12-23 |
1978-06-20 |
Alza Corporation |
Method for administering drug to the gastrointestinal tract
|
US4014335A
(en)
|
1975-04-21 |
1977-03-29 |
Alza Corporation |
Ocular drug delivery device
|
NL188266C
(nl)
|
1975-07-29 |
1992-05-18 |
Merck & Co Inc |
Werkwijze ter bereiding van een oogheelkundig inplantaat.
|
US4034758A
(en)
|
1975-09-08 |
1977-07-12 |
Alza Corporation |
Osmotic therapeutic system for administering medicament
|
US3977404A
(en)
|
1975-09-08 |
1976-08-31 |
Alza Corporation |
Osmotic device having microporous reservoir
|
US4014333A
(en)
|
1975-09-22 |
1977-03-29 |
Mcintyre David J |
Instrument for aspirating and irrigating during ophthalmic surgery
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4014334A
(en)
|
1976-02-02 |
1977-03-29 |
Alza Corporation |
Laminated osmotic system for dispensing beneficial agent
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
US4160452A
(en)
|
1977-04-07 |
1979-07-10 |
Alza Corporation |
Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
US4164559A
(en)
|
1977-09-21 |
1979-08-14 |
Cornell Research Foundation, Inc. |
Collagen drug delivery device
|
US4186184A
(en)
|
1977-12-27 |
1980-01-29 |
Alza Corporation |
Selective administration of drug with ocular therapeutic system
|
US4220152A
(en)
|
1978-05-08 |
1980-09-02 |
Pfizer Inc. |
Delivery system
|
US4220153A
(en)
|
1978-05-08 |
1980-09-02 |
Pfizer Inc. |
Controlled release delivery system
|
US4200098A
(en)
|
1978-10-23 |
1980-04-29 |
Alza Corporation |
Osmotic system with distribution zone for dispensing beneficial agent
|
US4298000A
(en)
|
1978-11-08 |
1981-11-03 |
Minnesota Mining And Manufacturing Company |
Fluid dispensing device
|
US4300557A
(en)
|
1980-01-07 |
1981-11-17 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method for treating intraocular malignancies
|
US4309776A
(en)
|
1980-05-13 |
1982-01-12 |
Ramon Berguer |
Intravascular implantation device and method of using the same
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
US4484922A
(en)
|
1981-06-25 |
1984-11-27 |
Rosenwald Peter L |
Occular device
|
US4439198A
(en)
|
1981-07-09 |
1984-03-27 |
University Of Illinois Foundation |
Biodegradable ocular insert for controlled delivery of ophthalmic medication
|
US4730013A
(en)
|
1981-10-08 |
1988-03-08 |
Merck & Co., Inc. |
Biosoluble ocular insert
|
US4475916A
(en)
|
1982-03-18 |
1984-10-09 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4519801A
(en)
|
1982-07-12 |
1985-05-28 |
Alza Corporation |
Osmotic device with wall comprising cellulose ether and permeability enhancer
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
US4883459A
(en)
|
1983-07-29 |
1989-11-28 |
Reynaldo Calderon |
Retrograde perfusion
|
US4774091A
(en)
|
1983-10-14 |
1988-09-27 |
Sumitomo Pharmaceuticals Company, Ltd. |
Long-term sustained-release preparation
|
US4627850A
(en)
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4777049A
(en)
|
1983-12-01 |
1988-10-11 |
Alza Corporation |
Constant release system with pulsed release
|
US4634418A
(en)
|
1984-04-06 |
1987-01-06 |
Binder Perry S |
Hydrogel seton
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
US5049142A
(en)
|
1984-11-07 |
1991-09-17 |
Herrick Robert S |
Intracanalicular implant for horizontal canalicular blockade treatment of the eye
|
US5053030A
(en)
|
1984-11-07 |
1991-10-01 |
Herrick Robert S |
Intracanalicular implant for horizontal canalicular blockade treatment of the eye
|
US4712550A
(en)
|
1985-04-08 |
1987-12-15 |
Sinnett Kevin B |
Retinal tack
|
US4693886A
(en)
|
1985-04-22 |
1987-09-15 |
Alza Corporation |
Osmotic device with inert core
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
EP0201611A1
(de)
|
1985-05-10 |
1986-11-20 |
B. Braun-SSC AG |
Zwei-Kanülen-Spritze
|
CA1314481C
(en)
|
1986-12-23 |
1993-03-16 |
Marcel B. Bally |
Liposomal preparation and antibiotic
|
US4781675A
(en)
|
1985-11-27 |
1988-11-01 |
White Thomas C |
Infusion cannula
|
DE3672981D1
(de)
|
1985-11-27 |
1990-08-30 |
Thomas C White |
Gewebeimplantierbare fluessigkeitsverteileinrichtung.
|
US4959217A
(en)
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
US5147647A
(en)
|
1986-10-02 |
1992-09-15 |
Sohrab Darougar |
Ocular insert for the fornix
|
US5322691A
(en)
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
US4863457A
(en)
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
US4853229A
(en)
|
1987-10-26 |
1989-08-01 |
Alza Corporation |
Method for adminstering tiny pills
|
JP2702953B2
(ja)
|
1988-01-30 |
1998-01-26 |
オリンパス光学工業株式会社 |
薬液含浸セラミックス
|
US4865846A
(en)
|
1988-06-03 |
1989-09-12 |
Kaufman Herbert E |
Drug delivery system
|
US5174999A
(en)
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
AU4951690A
(en)
|
1988-12-30 |
1990-08-01 |
David M. Anderson |
Stabilized microporous materials and hydrogel materials
|
US5141748A
(en)
|
1989-02-17 |
1992-08-25 |
Hoffmann-La Roche, Inc. |
Implant drug delivery device
|
US5098443A
(en)
|
1989-03-23 |
1992-03-24 |
University Of Miami |
Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
|
US4979938A
(en)
|
1989-05-11 |
1990-12-25 |
Iomed, Inc. |
Method of iontophoretically treating acne, furuncles and like skin disorders
|
US5164188A
(en)
|
1989-11-22 |
1992-11-17 |
Visionex, Inc. |
Biodegradable ocular implants
|
US5171270A
(en)
|
1990-03-29 |
1992-12-15 |
Herrick Robert S |
Canalicular implant having a collapsible flared section and method
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
US5128145A
(en)
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5238687A
(en)
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5084021A
(en)
|
1990-11-02 |
1992-01-28 |
Baldwin Brian E |
Patient controlled infusion apparatus and method
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
AU650113B2
(en)
|
1991-04-05 |
1994-06-09 |
Eli Lilly And Company |
Sustained release capsule and formulations
|
US5334189A
(en)
|
1991-06-03 |
1994-08-02 |
Wade Stephen E |
Device for controlled diffusion of a chemical substance
|
US5213576A
(en)
|
1991-06-11 |
1993-05-25 |
Cordis Corporation |
Therapeutic porous balloon catheter
|
US5282829A
(en)
|
1991-08-15 |
1994-02-01 |
United States Surgical Corporation |
Hollow body implants
|
FR2682090B1
(fr)
|
1991-10-03 |
1993-12-31 |
Holzstoff Holding Sa |
Systeme-reservoir pour diffusion prolongee d'un principe actif.
|
US5681572A
(en)
|
1991-10-18 |
1997-10-28 |
Seare, Jr.; William J. |
Porous material product and process
|
US5178635A
(en)
|
1992-05-04 |
1993-01-12 |
Allergan, Inc. |
Method for determining amount of medication in an implantable device
|
US6096756A
(en)
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
CA2140053C
(en)
|
1994-02-09 |
2000-04-04 |
Joel S. Rosenblatt |
Collagen-based injectable drug delivery system and its use
|
US5985328A
(en)
|
1994-03-07 |
1999-11-16 |
Regents Of The University Of California |
Micromachined porous membranes with bulk support
|
US5770076A
(en)
|
1994-03-07 |
1998-06-23 |
The Regents Of The University Of California |
Micromachined capsules having porous membranes and bulk supports
|
US5578042A
(en)
|
1994-03-14 |
1996-11-26 |
Cumming; J. Stuart |
Ophthalmic kit and method for lens insertion
|
US5466233A
(en)
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
AUPM897594A0
(en)
|
1994-10-25 |
1994-11-17 |
Daratech Pty Ltd |
Controlled release container
|
AU708529B2
(en)
|
1994-11-10 |
1999-08-05 |
University Of Kentucky Research Foundation, The |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
|
US5725493A
(en)
|
1994-12-12 |
1998-03-10 |
Avery; Robert Logan |
Intravitreal medicine delivery
|
US5554132A
(en)
|
1995-03-30 |
1996-09-10 |
Abbott Laboratories |
Hand grip for use with syringe
|
IL113723A
(en)
|
1995-05-14 |
2002-11-10 |
Optonol Ltd |
Intraocular implant
|
CN1283324C
(zh)
|
1995-05-14 |
2006-11-08 |
奥普通诺尔有限公司 |
眼内植入物、植入装置、以及植入方法
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
US5773019A
(en)
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
US6641708B1
(en)
|
1996-01-31 |
2003-11-04 |
Board Of Regents, The University Of Texas System |
Method and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation
|
GB2310149A
(en)
|
1996-02-15 |
1997-08-20 |
Nomix Chipman Ltd |
Spray gun
|
US20090005864A1
(en)
|
1996-03-18 |
2009-01-01 |
Eggleston Harry C |
Modular intraocular implant
|
US5904144A
(en)
|
1996-03-22 |
1999-05-18 |
Cytotherapeutics, Inc. |
Method for treating ophthalmic diseases
|
US5951512A
(en)
|
1996-05-28 |
1999-09-14 |
Horizon Medical Products, Inc. |
Infusion port with modified drug reservoir
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
US5928662A
(en)
|
1996-07-31 |
1999-07-27 |
Phillips; Andrew F. |
Ocular drug delivery device
|
AU7533696A
(en)
|
1996-12-13 |
1998-06-18 |
Ciba-Geigy Ag |
New materials
|
DK0973499T3
(da)
|
1997-03-31 |
2003-11-17 |
Alza Corp |
Implanterbart diffusionsafgivelsessystem
|
US7160687B1
(en)
|
1997-05-29 |
2007-01-09 |
Cellomics, Inc. |
Miniaturized cell array methods and apparatus for cell-based screening
|
US6306426B1
(en)
|
1997-08-11 |
2001-10-23 |
Allergan Sales, Inc. |
Implant device with a retinoid for improved biocompatibility
|
US5902598A
(en)
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6183461B1
(en)
|
1998-03-11 |
2001-02-06 |
Situs Corporation |
Method for delivering a medication
|
US6196993B1
(en)
|
1998-04-20 |
2001-03-06 |
Eyelab Group, Llc |
Ophthalmic insert and method for sustained release of medication to the eye
|
US5993414A
(en)
|
1998-04-23 |
1999-11-30 |
Medtronic, Inc. |
Implantable device
|
FR2784296B1
(fr)
|
1998-09-18 |
2001-01-05 |
Imedex Biomateriaux |
Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
|
US7973068B2
(en)
|
1998-10-20 |
2011-07-05 |
Omeros Corporation |
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
|
DE19948783C2
(de)
|
1999-02-18 |
2001-06-13 |
Alcove Surfaces Gmbh |
Implantat
|
US7914442B1
(en)
|
1999-03-01 |
2011-03-29 |
Gazdzinski Robert F |
Endoscopic smart probe and method
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6472162B1
(en)
|
1999-06-04 |
2002-10-29 |
Thermogenesis Corp. |
Method for preparing thrombin for use in a biological glue
|
AU770975B2
(en)
|
1999-06-18 |
2004-03-11 |
Alcon Laboratories, Inc. |
Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
|
US6638263B1
(en)
|
1999-10-12 |
2003-10-28 |
Durect Corporation |
Regulation of drug delivery through flow diversion
|
ATE283013T1
(de)
|
1999-10-21 |
2004-12-15 |
Alcon Inc |
Medikamentenzuführvorrichtung
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
US20050119737A1
(en)
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US20030212383A1
(en)
|
2001-01-05 |
2003-11-13 |
Dana Cote |
System and methods for reducing intraocular pressure
|
RU2262331C2
(ru)
|
2000-01-12 |
2005-10-20 |
Бектон, Дикинсон Энд Компани |
Шунт, имплантат, система и способ снижения внутриглазного давления, способ изготовления имплантата для роговицы (варианты)
|
DE10008826C2
(de)
|
2000-02-25 |
2002-03-14 |
Disetronic Licensing Ag |
Mikroperfusionsvorrichtung mit Sammelbehältnis
|
US7077848B1
(en)
|
2000-03-11 |
2006-07-18 |
John Hopkins University |
Sutureless occular surgical methods and instruments for use in such methods
|
WO2001068377A1
(fr)
|
2000-03-13 |
2001-09-20 |
Seiko Epson Corporation |
Procede de traitement de surface, article traite en surface et dispositif de traitement de surface
|
US7141152B2
(en)
|
2000-03-16 |
2006-11-28 |
Le Febre David A |
Analyte species separation system
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
ATE547080T1
(de)
*
|
2000-08-30 |
2012-03-15 |
Univ Johns Hopkins |
Vorrichtungen zur intraokularen arzneimittelabgabe
|
DE60131773T2
(de)
|
2000-09-06 |
2008-04-10 |
Alcon Inc. |
Beschichtungsmittel mit veränderbarer klebrigkeit für augenimplantate
|
US6303290B1
(en)
|
2000-09-13 |
2001-10-16 |
The Trustees Of The University Of Pennsylvania |
Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
|
WO2002056863A2
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
WO2002053129A1
(en)
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
DE60130928T2
(de)
|
2001-01-03 |
2008-07-17 |
Bausch & Lomb Inc. |
Vorrichtung zur verzögerten wirkstofffreisetzung mit beschichteten medikamentenkernen
|
JP4657577B2
(ja)
|
2001-01-09 |
2011-03-23 |
マイクロチップス・インコーポレーテッド |
眼への適用および他への適用のための可撓性マイクロチップデバイス
|
JP2004520900A
(ja)
|
2001-01-26 |
2004-07-15 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬剤送達装置の改良製造方法
|
US7181287B2
(en)
|
2001-02-13 |
2007-02-20 |
Second Sight Medical Products, Inc. |
Implantable drug delivery device
|
US6713081B2
(en)
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
EP1404297B1
(en)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
JP4426286B2
(ja)
|
2001-07-10 |
2010-03-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
0次、0次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
|
IL144446A0
(en)
|
2001-07-19 |
2002-05-23 |
Prochon Biotech Ltd |
Plasma protein matrices and methods for their preparation
|
AU2002319606B2
(en)
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
EP1409065B1
(en)
|
2001-07-23 |
2007-01-17 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
CN1538826A
(zh)
|
2001-08-03 |
2004-10-20 |
青光眼研究科技公司 |
治疗青光眼及老花眼的方法及其内巩膜植入物
|
US7749528B2
(en)
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
RU2311892C2
(ru)
|
2001-08-29 |
2007-12-10 |
КАРВАЛХО Рикардо А. П. ДЕ |
Имплантируемая и герметизируемая система для однонаправленной доставки терапевтических препаратов в ткани
|
US20030118649A1
(en)
|
2001-10-04 |
2003-06-26 |
Jinming Gao |
Drug delivery devices and methods
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
JP2005509883A
(ja)
|
2001-11-15 |
2005-04-14 |
アリックス,インコーポレーテッド |
試料チップ
|
CA2473355C
(en)
|
2002-01-18 |
2012-01-03 |
Michael E. Snyder |
Sustained release ophthalmological device and method of making and using the same
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
MXPA04008903A
(es)
|
2002-03-11 |
2004-11-26 |
Alcon Inc |
Sistema de suministro de farmaco implantable.
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
US7939094B2
(en)
|
2002-06-19 |
2011-05-10 |
Boston Scientific Scimed, Inc. |
Multiphase polymeric drug release region
|
WO2004006889A1
(en)
|
2002-07-15 |
2004-01-22 |
Alcon, Inc. |
Bioerodible film for ophthalmic drug delivery
|
US8425549B2
(en)
|
2002-07-23 |
2013-04-23 |
Reverse Medical Corporation |
Systems and methods for removing obstructive matter from body lumens and treating vascular defects
|
US20040019325A1
(en)
|
2002-07-29 |
2004-01-29 |
Medrip Ltd. |
Syringe Pump
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
AU2003272575B2
(en)
|
2002-09-18 |
2007-11-08 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
US20050143363A1
(en)
|
2002-09-29 |
2005-06-30 |
Innorx, Inc. |
Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
|
US7794437B2
(en)
|
2003-01-24 |
2010-09-14 |
Doheny Retina Institute |
Reservoirs with subretinal cannula for subretinal drug delivery
|
WO2004073551A2
(en)
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US20060258000A1
(en)
|
2003-02-26 |
2006-11-16 |
Allen Jared W |
Use of steady-state oxygen gradients to modulate animal cell functions
|
US20050074497A1
(en)
|
2003-04-09 |
2005-04-07 |
Schultz Clyde L. |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
US20050255144A1
(en)
|
2003-04-09 |
2005-11-17 |
Directcontact Llc |
Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
|
EP1671624B1
(en)
|
2003-05-02 |
2010-08-11 |
SurModics, Inc. |
Delivery device for a controlled drug release of an active agent into the posterior section of the eye
|
CA2524271C
(en)
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
CA2529048A1
(en)
|
2003-06-13 |
2005-02-24 |
Becton, Dickinson And Company |
Improved intra-dermal delivery of biologically active agents
|
US20040260381A1
(en)
|
2003-06-18 |
2004-12-23 |
D-Crown Ltd |
Devices and methods for forming stenting structures in situ
|
WO2004112653A2
(en)
|
2003-06-18 |
2004-12-29 |
D-Crown Ltd. |
Devices and methods for delivering and forming single and multiple stenting structures in situ
|
US20040260380A1
(en)
|
2003-06-18 |
2004-12-23 |
D-Crown Ltd |
Devices for delivering multiple stenting structures in situ
|
US8367410B2
(en)
|
2003-06-20 |
2013-02-05 |
Massachusetts Institute Of Technology |
Application of electrical stimulation for functional tissue engineering in vitro and in vivo
|
ZA200508654B
(en)
|
2003-07-10 |
2007-01-31 |
Alcon Inc |
Ophthalmic drug delivery device
|
FI120333B
(fi)
|
2003-08-20 |
2009-09-30 |
Bioretec Oy |
Huokoinen lääketieteellinen väline ja menetelmä sen valmistamiseksi
|
AU2004274026A1
(en)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US20050181018A1
(en)
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
NZ546730A
(en)
|
2003-09-24 |
2008-04-30 |
Medi Stream Pty Ltd |
Medication holder
|
AU2006225241B2
(en)
|
2003-09-24 |
2008-07-17 |
Tianda Pharmaceuticals (Australia) Pty Limited |
Medication Holder
|
US7615141B2
(en)
|
2003-10-03 |
2009-11-10 |
University Of Washington |
Electrochemical micromanufacturing system and method
|
US7211272B2
(en)
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
BRPI0507690A
(pt)
|
2004-02-12 |
2007-07-24 |
Neovista Inc |
métodos e aparelho para a braquiterapia intra-ocular
|
US7276050B2
(en)
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
US20050256499A1
(en)
|
2004-03-03 |
2005-11-17 |
Pettis Ronald J |
Methods and devices for improving delivery of a substance to skin
|
US20050244472A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US8591885B2
(en)
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20060182783A1
(en)
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20070059336A1
(en)
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
US20060110428A1
(en)
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
AU2005269988B2
(en)
|
2004-07-02 |
2012-02-02 |
Mati Therapeutics Inc. |
Treatment medium delivery device and methods for delivery
|
US7117870B2
(en)
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
US20060020253A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Prescott Anthony D |
Implantable device having reservoir with controlled release of medication and method of manufacturing the same
|
WO2006015385A2
(en)
|
2004-08-06 |
2006-02-09 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
WO2006031358A2
(en)
|
2004-08-13 |
2006-03-23 |
Hyperbranch Medical Technology, Inc. |
Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
|
WO2006023530A2
(en)
|
2004-08-16 |
2006-03-02 |
Massachusetts Institute Of Technology |
Compositions and methods for enhancing structural and functional nervous system reorganization and recovery
|
WO2006031388A2
(en)
|
2004-08-20 |
2006-03-23 |
Hyperbranch Medical Technology, Inc. |
Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
|
US20060052754A1
(en)
|
2004-09-04 |
2006-03-09 |
Fields Douglas W |
Thumb trigger syringe pole
|
WO2006031532A2
(en)
|
2004-09-10 |
2006-03-23 |
Surmodics, Inc. |
Methods, devices, and coatings for controlled active agent release
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
AU2005292145C1
(en)
|
2004-10-01 |
2011-07-21 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
WO2006044614A2
(en)
|
2004-10-14 |
2006-04-27 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
EP1817003B1
(en)
|
2004-10-29 |
2018-02-21 |
The Regents of The University of California |
Porous silicon microparticles for drug delivery to the eye
|
US20060129215A1
(en)
|
2004-12-09 |
2006-06-15 |
Helmus Michael N |
Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
|
US20060154981A1
(en)
|
2005-01-12 |
2006-07-13 |
Alcon, Inc. |
Method of reducing intraocular pressure and treating glaucoma
|
WO2006082588A2
(en)
|
2005-02-07 |
2006-08-10 |
Pharmalight Inc. |
Method and device for ophthalmic administration of active pharmaceutical ingredients
|
US20060233858A1
(en)
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
KR20070121754A
(ko)
|
2005-03-21 |
2007-12-27 |
마커사이트, 인코포레이티드 |
질환 또는 상태의 치료를 위한 약물 송달 시스템
|
US20070066138A1
(en)
|
2005-04-05 |
2007-03-22 |
The Ohio State University Research Foundation |
Diffusion Delivery Systems and Methods of Fabrication
|
US20100168535A1
(en)
|
2006-04-12 |
2010-07-01 |
Mark Ries Robinson |
Methods and apparatuses related to blood analyte measurement system
|
US20060258994A1
(en)
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
US20070088414A1
(en)
|
2005-05-25 |
2007-04-19 |
Campbell Robert L |
Particulate formulations for intradermal delivery of biologically active agents
|
JP2009501700A
(ja)
|
2005-06-17 |
2009-01-22 |
ダイナミス・セラピユーテイクス・インコーポレーテツド |
炎症状態の治療
|
US7893040B2
(en)
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
US8663673B2
(en)
|
2005-07-29 |
2014-03-04 |
Surmodics, Inc. |
Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
JP2009508593A
(ja)
|
2005-09-16 |
2009-03-05 |
(オーエスアイ)アイテツク・インコーポレーテツド |
眼科用シリンジ
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
US20080003219A1
(en)
|
2005-09-26 |
2008-01-03 |
Minu, L.L.C. |
Delivery of an ocular agent
|
US20070072933A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an ocular agent
|
WO2007038453A2
(en)
|
2005-09-26 |
2007-04-05 |
Advanced Ocular Systems Limited |
Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
|
US20080167600A1
(en)
|
2005-09-26 |
2008-07-10 |
Peyman Gholam A |
Device for delivery of an agent to the eye and other sites
|
TW200732347A
(en)
|
2005-10-06 |
2007-09-01 |
Trophogen Inc |
VEGF analogs and methods of use
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
EP1948112A4
(en)
|
2005-10-11 |
2011-04-13 |
Podaima Blake |
SMART MEDICAL COMPLIANCE PROCESS AND SYSTEM
|
US20080125406A1
(en)
|
2005-10-14 |
2008-05-29 |
Robin Alan L |
Method for Treating Primary and Secondary Forms of Glaucoma
|
WO2007047744A2
(en)
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Method for treating primary and secondary forms of glaucoma
|
MX2008006379A
(es)
|
2005-11-29 |
2009-03-03 |
Smithkline Beecham Corp |
Metodo de tratamiento.
|
JP4721425B2
(ja)
|
2005-12-01 |
2011-07-13 |
キヤノン株式会社 |
流体移動方法および流体移動装置
|
WO2007066339A1
(en)
|
2005-12-07 |
2007-06-14 |
Ramot At Tel Aviv University Ltd. |
Drug-delivering composite structures
|
US20070131610A1
(en)
|
2005-12-13 |
2007-06-14 |
General Electric Company |
Membrane-based apparatus and associated method
|
US20070131611A1
(en)
|
2005-12-13 |
2007-06-14 |
General Electric Company |
Membrane-based article and associated method
|
EP3632385A1
(en)
|
2006-01-17 |
2020-04-08 |
Novartis AG |
Glaucoma treatment device
|
US9084662B2
(en)
|
2006-01-17 |
2015-07-21 |
Transcend Medical, Inc. |
Drug delivery treatment device
|
US20080216736A1
(en)
|
2006-01-19 |
2008-09-11 |
Takeda San Diego, Inc. |
Microfluidic device with diffusion between adjacent lumens
|
WO2007100986A2
(en)
|
2006-02-24 |
2007-09-07 |
Rosetta Inpharmatics Llc |
Extraction and diagnostic fluid devices, systems and methods of use
|
WO2007101204A1
(en)
|
2006-02-27 |
2007-09-07 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
TW200800230A
(en)
|
2006-03-31 |
2008-01-01 |
Dynamis Therapeutics Inc |
Composition and method related to fructosamine-3-kinase inhibitors
|
KR20110038144A
(ko)
*
|
2006-03-31 |
2011-04-13 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
비루관계에 대한 약물 전달 방법, 구조, 및 조성물
|
US8007461B2
(en)
|
2006-04-18 |
2011-08-30 |
Pingan Huo |
Sterile drug-mixing syringe
|
US8197435B2
(en)
|
2006-05-02 |
2012-06-12 |
Emory University |
Methods and devices for drug delivery to ocular tissue using microneedle
|
WO2007131050A2
(en)
|
2006-05-02 |
2007-11-15 |
Georgia Tech Research Corporation |
Method for drug delivery to ocular tissue using microneedle
|
US20080124372A1
(en)
|
2006-06-06 |
2008-05-29 |
Hossainy Syed F A |
Morphology profiles for control of agent release rates from polymer matrices
|
EP2037882B1
(en)
|
2006-06-28 |
2014-12-10 |
SurModics, Inc. |
Combination degradable and non-degradable matrices for active agent delivery
|
TW200815045A
(en)
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
WO2008009120A2
(en)
|
2006-07-19 |
2008-01-24 |
Noab Biodiscoveries Inc. |
Method and device to extract components contained in a fluid
|
CA2657380A1
(en)
|
2006-07-20 |
2008-01-24 |
Neurosystec Corporation |
Devices, systems and methods for ophthalmic drug delivery
|
US20080069854A1
(en)
|
2006-08-02 |
2008-03-20 |
Inframat Corporation |
Medical devices and methods of making and using
|
JP2008054521A
(ja)
|
2006-08-29 |
2008-03-13 |
Canon Inc |
細胞培養処理装置及び細胞培養処理方法
|
WO2008033924A2
(en)
|
2006-09-12 |
2008-03-20 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
US9149750B2
(en)
|
2006-09-29 |
2015-10-06 |
Mott Corporation |
Sinter bonded porous metallic coatings
|
US20080089923A1
(en)
|
2006-09-29 |
2008-04-17 |
Burkstrand Michael J |
Biodegradable ocular implants and methods for treating ocular conditions
|
TW200817039A
(en)
|
2006-10-06 |
2008-04-16 |
Dynamis Therapeutics Inc |
Compositions and methods for skin lightening
|
US9022970B2
(en)
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
US8784898B2
(en)
|
2006-10-25 |
2014-07-22 |
Revalesio Corporation |
Methods of wound care and treatment
|
WO2008052145A2
(en)
|
2006-10-25 |
2008-05-02 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
|
US8784897B2
(en)
|
2006-10-25 |
2014-07-22 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
US8609148B2
(en)
|
2006-10-25 |
2013-12-17 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
AU2007349224B2
(en)
|
2006-10-25 |
2014-04-03 |
Revalesio Corporation |
Methods of wound care and treatment
|
US8506515B2
(en)
|
2006-11-10 |
2013-08-13 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
US20080111282A1
(en)
|
2006-11-10 |
2008-05-15 |
Baojun Xie |
Process for Making Three Dimensional Objects From Dispersions of Polymer Colloidal Particles
|
US20100286791A1
(en)
*
|
2006-11-21 |
2010-11-11 |
Goldsmith David S |
Integrated system for the ballistic and nonballistic infixion and retrieval of implants
|
WO2008070118A1
(en)
|
2006-12-05 |
2008-06-12 |
Landec Corporation |
Drug delivery
|
US20090263346A1
(en)
|
2006-12-05 |
2009-10-22 |
David Taft |
Systems and methods for delivery of drugs
|
WO2008073295A2
(en)
|
2006-12-07 |
2008-06-19 |
Surmodics, Inc. |
Latent stabilization of bioactive agents releasable from implantable medical articles
|
US20080147021A1
(en)
|
2006-12-15 |
2008-06-19 |
Jani Dharmendra M |
Drug delivery devices
|
WO2008076544A2
(en)
|
2006-12-18 |
2008-06-26 |
Alcon Research, Ltd. |
Devices and methods for ophthalmic drug delivery
|
JP2010514517A
(ja)
|
2006-12-26 |
2010-05-06 |
キューエルティー プラグ デリバリー,インク. |
視覚欠損の抑制のための薬物送達インプラント
|
JP5201744B2
(ja)
|
2007-01-09 |
2013-06-05 |
フォヴェア ファルマシューティカル |
眼内注射装置
|
AU2008206953A1
(en)
|
2007-01-19 |
2008-07-24 |
Cinvention Ag |
Porous, non-degradable implant made by powder molding
|
UY30883A1
(es)
|
2007-01-31 |
2008-05-31 |
Alcon Res |
Tapones punctales y metodos de liberacion de agentes terapeuticos
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
US20080249501A1
(en)
|
2007-04-09 |
2008-10-09 |
Medtronic Vascular, Inc. |
Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure
|
US20080286338A1
(en)
|
2007-05-15 |
2008-11-20 |
Boston Foundation For Sight |
Drug delivery system with scleral lens
|
US8231892B2
(en)
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
CA2688344C
(en)
|
2007-05-29 |
2019-09-03 |
Angiochem, Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
US20090036827A1
(en)
|
2007-07-31 |
2009-02-05 |
Karl Cazzini |
Juxtascleral Drug Delivery and Ocular Implant System
|
WO2009023615A1
(en)
|
2007-08-10 |
2009-02-19 |
Trustees Of Tufts College |
Tubular silk compositions and methods of use thereof
|
KR101996336B1
(ko)
|
2007-09-07 |
2019-07-04 |
마티 테라퓨틱스 인코포레이티드 |
치료 약제의 서방성 약물 코어
|
CA2698580C
(en)
|
2007-09-07 |
2016-10-11 |
Qlt Plug Delivery, Inc. |
Lacrimal implant detection
|
EP2205192A2
(en)
|
2007-09-07 |
2010-07-14 |
QLT Plug Delivery, Inc. |
Insertion and extraction tools for lacrimal implants
|
US8308755B2
(en)
|
2007-09-24 |
2012-11-13 |
Ethicon Endo-Surgery, Inc. |
Elliptical retractor
|
US20090214601A1
(en)
|
2007-09-28 |
2009-08-27 |
Chappa Ralph A |
Porous Drug Delivery Devices and Related Methods
|
KR101511497B1
(ko)
|
2007-10-05 |
2015-04-13 |
코비디엔 엘피 |
수술 절차에 사용하기 위한 밀봉부 고정구
|
US20100100043A1
(en)
|
2007-10-05 |
2010-04-22 |
Racenet Danyel J |
Flexible Access Device For Use In Surgical Procedure
|
US20100008997A1
(en)
|
2007-10-25 |
2010-01-14 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
AU2008316708A1
(en)
|
2007-10-25 |
2009-04-30 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
WO2010062628A1
(en)
|
2008-10-27 |
2010-06-03 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
US20100303917A1
(en)
|
2007-10-25 |
2010-12-02 |
Revalesio Corporation |
Compositions and methods for treating cystic fibrosis
|
US20100303918A1
(en)
|
2007-10-25 |
2010-12-02 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
US20100310665A1
(en)
|
2007-10-25 |
2010-12-09 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US10125359B2
(en)
|
2007-10-25 |
2018-11-13 |
Revalesio Corporation |
Compositions and methods for treating inflammation
|
US20090263495A1
(en)
|
2007-10-25 |
2009-10-22 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US9523090B2
(en)
|
2007-10-25 |
2016-12-20 |
Revalesio Corporation |
Compositions and methods for treating inflammation
|
US20100009008A1
(en)
|
2007-10-25 |
2010-01-14 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US20090227018A1
(en)
|
2007-10-25 |
2009-09-10 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
US20100004189A1
(en)
|
2007-10-25 |
2010-01-07 |
Revalesio Corporation |
Compositions and methods for treating cystic fibrosis
|
BRPI0819175A2
(pt)
|
2007-11-05 |
2015-05-05 |
Bausch & Lomb |
Composição farmacêutica oftálmica, e, método para proporcionar disponibilidade estendida de um componente farmacêutico em um ambiente ocular de um indivíduo, e, uso de pelo menos um componente farmacêutico, pelo menos um material imiscível em água e opcionalmente um composto modificador de viscosidade
|
US8114883B2
(en)
|
2007-12-04 |
2012-02-14 |
Landec Corporation |
Polymer formulations for delivery of bioactive materials
|
EP2666510B1
(en)
|
2007-12-20 |
2017-10-18 |
University Of Southern California |
Apparatus for controlled delivery of therapeutic agents
|
US8414646B2
(en)
|
2007-12-27 |
2013-04-09 |
Forsight Labs, Llc |
Intraocular, accommodating lens and methods of use
|
US20090192493A1
(en)
|
2008-01-03 |
2009-07-30 |
University Of Southern California |
Implantable drug-delivery devices, and apparatus and methods for refilling the devices
|
WO2009089409A2
(en)
|
2008-01-10 |
2009-07-16 |
Bausch & Lomb Incorporated |
Intravitreal injection system having coaxial cannulae and use thereof
|
WO2009094466A2
(en)
|
2008-01-22 |
2009-07-30 |
University Of Florida Research Foundation, Inc. |
Contact lenses for extended release of bioactive agents containing diffusion attenuators
|
US8201752B2
(en)
|
2008-03-10 |
2012-06-19 |
Vapore, Inc. |
Low energy vaporization of liquids: apparatus and methods
|
TNSN08110A1
(en)
|
2008-03-11 |
2009-07-14 |
Rekik Raouf Dr |
Drug delivery to the anterior and posterior segment of the eye from drops
|
WO2009117112A2
(en)
|
2008-03-21 |
2009-09-24 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents
|
KR101674492B1
(ko)
|
2008-03-31 |
2016-11-09 |
닛토덴코 가부시키가이샤 |
침투제 전달 시스템 및 그의 사용방법
|
DK2285439T3
(en)
|
2008-04-04 |
2014-03-24 |
Nektar Therapeutics |
Aerosoliseringsanorning
|
US20090258069A1
(en)
|
2008-04-15 |
2009-10-15 |
John Burnier |
Delivery of LFA-1 antagonists to the gastrointestinal system
|
CA2722002C
(en)
|
2008-04-30 |
2018-06-19 |
Qlt Plug Delivery, Inc. |
Composite lacrimal insert and related methods
|
WO2009134929A2
(en)
|
2008-05-01 |
2009-11-05 |
Revalesio Corporation |
Compositions and methods for treating digestive disorders
|
CN103394142B
(zh)
|
2008-05-08 |
2015-08-19 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
US8231609B2
(en)
|
2008-05-08 |
2012-07-31 |
Minipumps, Llc |
Drug-delivery pumps and methods of manufacture
|
US20100197512A1
(en)
|
2008-07-11 |
2010-08-05 |
Intellicyt |
Multi-Sample Particle Analyzer and Method for High Throughput Screening
|
EP2312993A4
(en)
|
2008-07-21 |
2015-03-11 |
Arstasis Inc |
DEVICES, METHODS AND KITS FOR FORMING TISSUE TRAYS
|
US20100023033A1
(en)
|
2008-07-25 |
2010-01-28 |
Medtronic Vescular, Inc. |
Hydrodynamic Thrombectomy Catheter
|
US20100022943A1
(en)
|
2008-07-25 |
2010-01-28 |
Medtronic Vascular, Inc. |
Hydrodynamic Thrombectomy Catheter
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
US8221353B2
(en)
|
2008-10-21 |
2012-07-17 |
KMG Pharma, Inc |
Intravitreal injection device and system
|
US7678078B1
(en)
|
2008-10-21 |
2010-03-16 |
KMG Pharma LLC |
Intravitreal injection device, system and method
|
DE102008054431B3
(de)
|
2008-12-09 |
2010-06-17 |
Pari Pharma Gmbh |
Aerosoltherapievorrichtung
|
US20100174272A1
(en)
|
2009-01-02 |
2010-07-08 |
Weiner Alan L |
In-situ refillable ophthalmic implant
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
PL2391419T3
(pl)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Dostarczanie leku do tylnego odcinka
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
TR201908314T4
(tr)
|
2009-02-20 |
2019-06-21 |
2 Bbb Medicines B V |
Glutatyon bazlı ilaç dağıtım sistemi.
|
US8424367B2
(en)
|
2009-03-04 |
2013-04-23 |
University Of South Carolina |
Systems and methods for measurement of gas permeation through polymer films
|
JP2012525396A
(ja)
|
2009-04-27 |
2012-10-22 |
レバレジオ コーポレイション |
インスリン耐性および真性糖尿病を治療するための組成物および方法
|
US8815292B2
(en)
|
2009-04-27 |
2014-08-26 |
Revalesio Corporation |
Compositions and methods for treating insulin resistance and diabetes mellitus
|
WO2010125416A1
(en)
|
2009-04-27 |
2010-11-04 |
Raouf Rekik |
Drug delivery to the anterior and posterior segments of the eye
|
CN102802541A
(zh)
|
2009-05-15 |
2012-11-28 |
阿尔斯塔西斯公司 |
在组织中形成管道的装置、方法和成套用具
|
WO2010135369A1
(en)
|
2009-05-18 |
2010-11-25 |
Dose Medical Corporation |
Drug eluting ocular implant
|
ES2921527T3
(es)
|
2009-06-03 |
2022-08-29 |
Forsight Vision5 Inc |
Administración de fármaco en segmento anterior
|
WO2011008896A2
(en)
|
2009-07-14 |
2011-01-20 |
Board Of Regents, The University Of Texas System |
Therapeutic methods using controlled delivery devices having zero order kinetics
|
US20110033933A1
(en)
|
2009-07-15 |
2011-02-10 |
Morteza Gharib |
Method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
|
US20110117083A1
(en)
|
2009-08-14 |
2011-05-19 |
Genentech, Inc. |
Biological markers for monitoring patient response to vegf antagonists
|
WO2011028850A1
(en)
|
2009-09-01 |
2011-03-10 |
Northwestern University |
Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
|
EP2480270A4
(en)
|
2009-09-21 |
2015-07-08 |
Harvard Apparatus Regenerative Technology Inc |
METHODS AND APPARATUSES FOR INTRODUCING CELLS INTO A TISSUE SITE
|
US20110238036A1
(en)
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
US10166142B2
(en)
*
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US8821474B2
(en)
*
|
2010-02-22 |
2014-09-02 |
Microsert Ltd. |
Slow release liquid drug delivery device
|
US8038650B2
(en)
|
2010-02-22 |
2011-10-18 |
Microsert Ltd. |
Slow release liquid drug delivery device
|
AR081364A1
(es)
|
2010-05-05 |
2012-08-29 |
Glaxo Wellcome Mfg Pte Ltd |
Composiciones farmaceuticas de pazopanib y metodos para su elaboracion
|
DE102010026334B4
(de)
*
|
2010-07-07 |
2014-10-23 |
Gebr. Brasseler Gmbh & Co. Kg |
Dentalwerkzeug
|
WO2012019139A1
(en)
*
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
EP3861969A1
(en)
*
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
EP2600920A4
(en)
*
|
2010-08-05 |
2017-10-04 |
Forsight Vision4, Inc. |
Subconjunctival implant for posterior segment drug delivery
|
US8864703B2
(en)
|
2010-10-05 |
2014-10-21 |
Alcon Research, Ltd. |
Drug introduction and placement system
|
WO2012065006A2
(en)
|
2010-11-11 |
2012-05-18 |
Forsight Vision4, Inc. |
Methods and apparatus to determine porous structures for drug delivery
|
CA2818612C
(en)
*
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
WO2012131583A2
(en)
|
2011-03-27 |
2012-10-04 |
Microsert Ltd. |
Miniature implanted drug delivery devices and inserter systems for introducing such devices
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
US10010448B2
(en)
*
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
AU2014236455B2
(en)
*
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
EP4302736A3
(en)
*
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US20140336619A1
(en)
|
2013-05-13 |
2014-11-13 |
Abbott Cardiovascular Systems Inc. |
Ophthalmic shunt and method
|
US10376413B2
(en)
*
|
2013-10-27 |
2019-08-13 |
Microsert Ltd. |
Implantable drug delivery device and a system and method for deployment of such devices
|
US9445941B2
(en)
|
2013-11-07 |
2016-09-20 |
Drug Delivery Company, Llc |
Bioresorbable drug eluting intravitreal implant system and method
|
US20160302965A1
(en)
*
|
2013-12-06 |
2016-10-20 |
Forsight Vision4, Inc. |
Implantable therapeutic devices
|
US10258503B2
(en)
*
|
2014-07-15 |
2019-04-16 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US10500091B2
(en)
*
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|